Static Chart Alterity Therapeutics Limited Nasdaq

Equities

Market Closed - Nasdaq Other stock markets 15:39:53 2024-05-31 EDT			5-day change	1st Jan Change
1.87 ^USD	-0.54%		-6.50%	-24.90%

05-08	Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review	CI
05-08	Alterity Therapeutics on Track to Complete Phase Two Trial of Lead Drug Candidate in November	MT

Duration

Period